Kymera Therapeutics, Inc.
KYMR
Classifica tra le azioni
#2152
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to... Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
Prezzo delle azioni
$113.68
Ultima sincronizzazione: 2026-10-21
Capitalizzazione di mercato
$9.35B
Variazione (1 giorno)
0.19%
Variazione (1 anno)
103.73%
Paese
US
Scambia Kymera Therapeutics, Inc. (KYMR)
Categoria
Healthcare
Storico del prezzo dell'azione per Kymera Therapeutics, Inc. (KYMR)
Prezzo di chiusura più alto: $109.14 il 2026-10-01
Prezzo di chiusura più basso: $31.67 il 2020-08-01
Prezzo di chiusura più basso: $31.67 il 2020-08-01
Storico del prezzo dell'azione di Kymera Therapeutics, Inc. dal 2020 al 2026
Andamento annuale del prezzo dell'azione
| Anno | Performance |
|---|---|
| 2026 (TTM) | 12.05% |
| 2025 | 87.59% |
| 2024 | 77.01% |
| 2023 | -11.39% |
| 2022 | -52.05% |
| 2021 | -12.80% |
| 2020 | 0.00% |
Prezzo dell'azione per aziende simili o concorrenti
| Azienda | Prezzo dell'azione | Variazione 1a% | Il paese |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $756.75 | 7.56% |
CH
|
